News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
389 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (18011)
Month
January (4450)
February (4428)
March (5683)
April (4545)
May (5703)
June (4805)
July (3912)
August (4762)
September (4260)
October (3860)
November (4837)
December (2683)
Day
2 (18)
3 (192)
4 (399)
5 (344)
6 (307)
7 (143)
8 (3)
9 (40)
10 (389)
11 (192)
12 (199)
13 (188)
14 (96)
15 (3)
16 (29)
17 (74)
18 (340)
19 (185)
20 (212)
21 (85)
22 (1)
23 (15)
24 (197)
25 (192)
26 (163)
27 (186)
28 (90)
29 (1)
30 (4)
31 (163)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
Autolus Therapeutics announces 2022 priorities
Autolus Therapeutics plc, a clinical-stage biopharmaceutical company developing next-generation programmed T cell therapies, announced its 2022 corporate priorities and provided guidance.
January 10, 2022
·
8 min read
Business
Autolus Therapeutics announces retirement of chief financial officer and succession plan
Autolus Therapeutics plc announced that Andrew J. Oakley plans to retire from his position as chief financial officer with effect from 31 March 2022 and will concentrate on non-executive director roles.
January 10, 2022
·
5 min read
Deals
Medtronic to Acquire Affera
Medtronic plc, a global leader in healthcare technology, announced that it has entered into a definitive agreement to acquire Affera, Inc., a Boston area-based, privately held medical technology company.
January 10, 2022
·
7 min read
Business
AskBio Names Philip Dana Chief Human Resources Officer
Asklepios BioPharmaceutical, Inc., a leading, clinical-stage adeno-associated virus gene therapy company and a wholly owned and independently operated subsidiary of Bayer AG, announced that Philip Dana has been appointed to its executive team as Chief Human Resources Officer.
January 10, 2022
·
5 min read
Alpha Tau Announces Results of First US Clinical Trial of Alpha DaRT™ in Malignant Skin & Soft Tissue Cancers, Showing Complete Response in All Ten Treated Tumors at Approximately 12 Weeks and No Product-Related Serious Adverse Events
Alpha Tau Medical Ltd., the developer of the innovative alpha-radiation cancer therapy Alpha DaRT™, announced that all ten patients in its US multi-center pilot trial of the Alpha DaRT for malignant skin & soft tissue cancers have reached the secondary endpoint for measurement of tumor response.
January 10, 2022
·
9 min read
BiondVax to Present at H.C. Wainwright Bioconnect Virtual Conference
BiondVax Pharmaceuticals Ltd. announced that it will present a company overview at the H.C. Wainwright Bioconnect Virtual Conference.
January 10, 2022
·
3 min read
Genetown
Selecta Biosciences and Ginkgo Bioworks Announce New Collaboration to Develop Next-Generation Gene Therapy Capsids
Selecta Biosciences, Inc., a biotechnology company leveraging its clinically validated ImmTOR™ platform to develop tolerogenic therapies that selectively mitigate unwanted immune responses, and Ginkgo Bioworks, the leading horizontal platform for cell programming, announced a collaboration to develop safer and more effective next-generation gene therapy viral capsids.
January 10, 2022
·
8 min read
Drug Development
Theseus Pharmaceuticals Announces First Patient Treated with THE-630 in Phase 1/2 Study in Patients with Advanced Gastrointestinal Stromal Tumors (GIST)
Theseus Pharmaceuticals, Inc. announced that the first patient has been treated in the Phase 1 portion of Theseus’ ongoing Phase 1/2 study to evaluate lead candidate, THE-630, in patients with advanced gastrointestinal stromal tumors.
January 10, 2022
·
7 min read
Genetown
Medically Home Announces a $110 Million Strategic Investment Led by Baxter International Inc., Global Medical Response and Cardinal Health to Advance Leadership in Hospital-Level Patient Care at Home
Medically Home announced a new, $110 million round of funding from strategic investors including Baxter International Inc., Global Medical Response and Cardinal Health who will each have representation on the company’s Board.
January 10, 2022
·
8 min read
BioMidwest
Co-Diagnostics, Inc. to Participate in the H.C. Wainwright 2022 BioConnect Virtual Conference on January 10-13
Co-Diagnostics, Inc., a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced that Co-Diagnostics will be featured at the H.C. Wainwright & Co. 2022 BioConnect Conference, being held virtually on January 10-13.
January 10, 2022
·
2 min read
Previous
22 of 39
Next